NU 2016-068
INVENTORS
SHORT DESCRIPTION
This platform uses fungal artificial chromosomes and ultra‐high mass accuracy LC-MS to profile secondary metabolites. It offers a rapid, scalable approach for natural product discovery in drug and agricultural research.
BACKGROUND
Current natural product discovery methods often rely on time-consuming extraction and screening processes. High costs and low throughput limit the ability to uncover novel bioactive compounds, leaving a significant gap in timely therapeutic and agricultural innovations.
ABSTRACT
The invention leverages untargeted LC-MS with ultrahigh mass accuracy to analyze secondary metabolite products from heterologously expressed fungal biosynthetic gene clusters. It captures full-length gene clusters via fungal artificial chromosomes and screens host transformants using a robust scoring system to link spectral features with specific clusters. The results demonstrate that this method systematically identifies novel metabolites and lays the groundwork for scalable natural product discovery.
MARKET OPPORTUNITY
The demand for natural products is surging across both the pharmaceutical and agricultural industries, creating a powerful dual-market opportunity. The global drug discovery market, valued at $78.3 billion in 2023, is increasingly turning to natural sources for novel therapeutic leads to combat complex diseases (Source: Grand View Research, 2024).
DEVELOPMENT STAGE
TRL-4 - Prototype Validated in Lab: Key functions have been demonstrated in a laboratory-scale prototype using LC-MS to profile fungal metabolites.
APPLICATIONS
ADVANTAGES
PUBLICATIONS
IP STATUS
Issued US Patent 10,808,256.